Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 386,240 shares at $21.74 ($8.5M) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($8.5M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.74 | 239,351 | $5.2M | 61.2% |
| 2 | $22.45 | 146,889 | $3.3M | 38.8% |
| Total | $22.01 avg | 386,240 | $8.5M | 100% |
| Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-04 | $392K | — | Filing → |